Brianna Hoffner reminds oncology nurses to collaborate with colleagues in other departments when treating patients with immune-related adverse events.
Brianna Hoffner, MSN, NP, RN, of the University of Colorado Cancer Center reminds nurses: "you're not an island," and emphasizes collaboration when treating patients with immune-related adverse events.
It's easy for oncology nurses to take on all the work themselves as they are used to managing so much of a patient's treatment. However, when it comes to complex immune-related adverse events, Hoffner encourages nurses to network with colleagues in other departments. Those specialists can advise on the best approaches for treatment.
Stopping ICIs at 1 or 2 Years May Not Compromise Survival in HNSCC
September 11th 2024This retrospective, population-based study shows strong efficacy across multiple patient subgroups and different lines of therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Stopping ICIs at 1 or 2 Years May Not Compromise Survival in HNSCC
September 11th 2024This retrospective, population-based study shows strong efficacy across multiple patient subgroups and different lines of therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.
2 Commerce Drive
Cranbury, NJ 08512